HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma

PURPOSE: Currently, the paucity of classical effective pharmacological drugs to treat esophageal squamous cell carcinoma (ESCC) is a major problem. The c-Myc (MYC) protein is a promising target as it is overexpressed in ESCC. MYC is a sensitive client protein of the heat shock protein 90 (HSP90) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Liuliu, Zou, Qingqing, Liu, Qian, Lin, Yiguang, Chen, Size
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156265/
https://www.ncbi.nlm.nih.gov/pubmed/32308431
http://dx.doi.org/10.2147/OTT.S245813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156265/
https://www.ncbi.nlm.nih.gov/pubmed/32308431
http://dx.doi.org/10.2147/OTT.S245813

Ejemplares similares